Donald E Stull

Summary

Affiliation: United BioSource Corporation
Country: USA

Publications

  1. ncbi Using the congestion quantifier seven-item test to assess change in patient symptoms and their impact
    Donald E Stull
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland 20814, USA
    Allergy Asthma Proc 29:295-303. 2008
  2. ncbi Relative strength of relationships of nasal congestion and ocular symptoms with sleep, mood and productivity
    Donald E Stull
    United BioSource Corporation, Center for Health Outcomes Research, London, UK
    Curr Med Res Opin 25:1785-92. 2009
  3. ncbi Optimal recall periods for patient-reported outcomes: challenges and potential solutions
    Donald E Stull
    Center for Health Outcomes Research, United BioSource Corporation, 20 Bloomsbury Square, London, UK
    Curr Med Res Opin 25:929-42. 2009
  4. ncbi The congestion quantifier five-item test for nasal congestion: refinement of the congestion quantifier seven-item test
    Donald E Stull
    Center for Health Outcomes Research, United BioSource Corporation, London, United Kingdom
    Am J Rhinol Allergy 24:34-8. 2010
  5. ncbi Analyzing growth and change: latent variable growth curve modeling with an application to clinical trials
    Donald E Stull
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 17:47-59. 2008
  6. ncbi Development and validation of the Congestion Quantifier seven-item test (CQ7): a screening tool for nasal congestion
    Donald E Stull
    United BioSource Corporation, Bethesda, MD 20814, USA
    Value Health 10:457-65. 2007
  7. ncbi Measuring functional performance in patients with COPD: a discussion of patient-reported outcome measures
    Donald E Stull
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Curr Med Res Opin 23:2655-65. 2007
  8. ncbi Relationship of nasal congestion with sleep, mood, and productivity
    Donald E Stull
    United BioSource Corporation, Bethesda, MD 20814, USA
    Curr Med Res Opin 23:811-9. 2007
  9. ncbi Development of a frequent heartburn index
    Donald E Stull
    United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 20:1023-34. 2011
  10. ncbi Use of latent growth curve models for assessing the effects of darbepoetin alfa on hemoglobin and fatigue
    Donald E Stull
    Center for Health Outcomes Research, United BioSource Corporation, 20 Bloomsbury Square, London WC1A 2NS, UK
    Contemp Clin Trials 31:172-9. 2010

Detail Information

Publications13

  1. ncbi Using the congestion quantifier seven-item test to assess change in patient symptoms and their impact
    Donald E Stull
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland 20814, USA
    Allergy Asthma Proc 29:295-303. 2008
    ..Analyses of responsiveness to change suggest that a three- to four-point improvement is meaningful to patients...
  2. ncbi Relative strength of relationships of nasal congestion and ocular symptoms with sleep, mood and productivity
    Donald E Stull
    United BioSource Corporation, Center for Health Outcomes Research, London, UK
    Curr Med Res Opin 25:1785-92. 2009
    ..Nasal congestion associated with allergic rhinitis has been shown to be the most bothersome symptom. Ocular symptoms may be troublesome to patients as well...
  3. ncbi Optimal recall periods for patient-reported outcomes: challenges and potential solutions
    Donald E Stull
    Center for Health Outcomes Research, United BioSource Corporation, 20 Bloomsbury Square, London, UK
    Curr Med Res Opin 25:929-42. 2009
    ..This paper draws on survey research, health-specific literature, and results from clinical trials to summarize factors that can influence recall and provide guidance on selecting an optimal recall period...
  4. ncbi The congestion quantifier five-item test for nasal congestion: refinement of the congestion quantifier seven-item test
    Donald E Stull
    Center for Health Outcomes Research, United BioSource Corporation, London, United Kingdom
    Am J Rhinol Allergy 24:34-8. 2010
    ..We explored further item reduction of the CQ7 and examined the psychometric properties of this reduced set of items in a 15-day study of patients with confirmed AR or self-identified and clinician-confirmed congestion...
  5. ncbi Analyzing growth and change: latent variable growth curve modeling with an application to clinical trials
    Donald E Stull
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 17:47-59. 2008
    ..This paper compares results from traditional regression-based methods for analyzing data from a clinical trial (e.g., regression with change scores) with those of latent growth curve modeling (LGM)...
  6. ncbi Development and validation of the Congestion Quantifier seven-item test (CQ7): a screening tool for nasal congestion
    Donald E Stull
    United BioSource Corporation, Bethesda, MD 20814, USA
    Value Health 10:457-65. 2007
    ..Nevertheless, there is no short screening tool designed specifically to identify congestion that can help patients make decisions about seeking treatment...
  7. ncbi Measuring functional performance in patients with COPD: a discussion of patient-reported outcome measures
    Donald E Stull
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Curr Med Res Opin 23:2655-65. 2007
    ....
  8. ncbi Relationship of nasal congestion with sleep, mood, and productivity
    Donald E Stull
    United BioSource Corporation, Bethesda, MD 20814, USA
    Curr Med Res Opin 23:811-9. 2007
    ..To explore the impact of nasal congestion alone relative to a full set of allergic rhinitis (AR) symptoms on sleep, fatigue, daytime somnolence, and work and school productivity in a 15-day prospective, naturalistic study...
  9. ncbi Development of a frequent heartburn index
    Donald E Stull
    United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 20:1023-34. 2011
    ..S. population, yielding a single, composite score...
  10. ncbi Use of latent growth curve models for assessing the effects of darbepoetin alfa on hemoglobin and fatigue
    Donald E Stull
    Center for Health Outcomes Research, United BioSource Corporation, 20 Bloomsbury Square, London WC1A 2NS, UK
    Contemp Clin Trials 31:172-9. 2010
    ..Latent growth models (LGMs) were used to examine simultaneously relationships among drug exposure, fatigue outcomes, covariates, and mediating factors...
  11. ncbi EQ-5D™-derived utility values for different levels of migraine severity from a UK sample of migraineurs
    Megan R Stafford
    Outcomes Research, United BioSource Corporation, 26 28 Hammersmith Grove, Floor 5E, London, W6 7HA, United Kingdom
    Health Qual Life Outcomes 10:65. 2012
    ..To estimate utility values for different levels of migraine pain severity from a United Kingdom (UK) sample of migraineurs...
  12. ncbi Longitudinal analysis of the reciprocal effects of self-assessed global health and depressive symptoms
    Karl Kosloski
    Department of Gerontology, University of Nebraska at Omaha, University of Nebraska Omaha, Omaha, NE 68182, USA
    J Gerontol B Psychol Sci Soc Sci 60:P296-P303. 2005
    ..There has been growing interest in identifying the factors that inform self-assessments of overall health. The present findings indicate that self-assessed global health is not simply a manifestation of depressed affect...
  13. ncbi The utility of multidimensional assessments of physical health in patient care
    Donald E Stull
    The MEDSTAT Group, Inc, Washington, DC 20008, USA
    AACN Clin Issues 14:251-60. 2003
    ..These findings suggest that, while related, each type of measure captures a different aspect of patient physical health and functioning...